Archived: Summary of NACI statement of March 8, 2024: Updated guidance on the use of protein subunit COVID-19 vaccine (Novavax Nuvaxovid)

ASEM 文献综述

Official National Advisory Committee on Immunization document (2024) on “Archived: Summary of NACI statement of March 8, 2024: Updated guidance on the use of protein subunit COVID-19 vaccine (Novavax Nuvaxovid)”. Valid as of March 8, 2024: Summary of the National Advisory Committee on Immunization's recommendations for the updated guidance on the use of protein subunit COVID-19 vaccine (Novavax Nuvaxovid).

此摘要有助于您识别文档。对于临床建议，请始终查阅官方现行版本及其更新日期。